Skip to main content
Equibles

Squarepoint Ops LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1642575 NEW YORK, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$582,653
+$356,413 QoQ
Shares Held
444,774
+210.6% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 130 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. LCTX ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in LCTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $582,653 444,774
2026-03-31 $226,240 143,190
2025-12-31 $108,732 65,109
2025-06-30 $465,107 511,107
2025-03-31 $160,997 357,772
2024-12-31 $46,000 92,001
2024-06-30 $44,307 44,307
2024-03-31 $284,004 191,895
2023-12-31 $188,894 173,298
2023-09-30 $29,064 24,631
2023-06-30 $45,014 31,925
2023-03-31 $49,284 32,856